RHBDL4-mediated APP cleavage is negatively regulated by cholesterol and decreases Aβ38, Aβ40 and Aβ42 levels, although these in vitro observations still need to be validated for their relevance regarding AD pathogenesis [79]. The gene discussed is APP; the disease is Alzheimer disease.